Brief: Arovella Therapeutics To Close Its Perth Oromist Research And Development Facility

Arovella Therapeutics

26/10/2022 03:06

Oct 26 (Reuters) - Arovella Therapeutics Ltd  ALA.AX :
    * AROVELLA TO CLOSE ITS PERTH OROMIST RESEARCH AND
DEVELOPMENT
FACILITY AND FOCUS ON ITS INKT CELL THERAPY PLATFORM
    * SEES CLOSURE OF FACILITY TO HAVE ESTIMATED COST SAVING OF
A$1.5M
PER ANNUM BASED ON HISTORICAL COSTS

Further company coverage:  ALA.AX 
 ((Reuters.Briefs@thomsonreuters.com;))